Century Therapeutics (IPSC) Change in Account Payables (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Change in Account Payables of -$1.6 million for Q1 2026, down 550.14% year-over-year from $361000.0 in Q1 2025, and down 175.34% quarter-over-quarter from $2.2 million in Q4 2025.
Powered by 
Analysis
Century Therapeutics (IPSC) Change in Account Payables (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Change in Account Payables for 7 consecutive years, with -$1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 550.14% year-over-year to -$1.6 million; the TTM figure through Mar 2026 stood at -$424000.0 (up 76.41% YoY), while the FY2025 annual figure was $1.6 million, up 206.33% from the prior year.
- Change in Account Payables eased to -$1.6 million in Q1 2026 per IPSC's latest filing, from $2.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.0 million in Q3 2023 and bottomed at -$3.0 million in Q1 2023.
- Historically, Change in Account Payables has averaged -$510647.1 across 5 years, with a median of -$591000.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Account Payables jumped 465.72% — and 2026, when it slumped 550.14%.
- Century Therapeutics' Change in Account Payables stood at -$1.6 million in 2022, then sank by 76.79% to -$2.9 million in 2023, then surged by 116.52% to $477000.0 in 2024, then jumped by 352.2% to $2.2 million in 2025, then slumped by 175.34% to -$1.6 million in 2026.
- Business Quant data shows IPSC's Change in Account Payables at -$1.6 million in Q1 2026, $2.2 million in Q4 2025, and -$591000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Century Therapeutics | 440.37 Mn | 180.29 Mn | - | 1.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.67 Mn |
| Mar 31, 2026 | -1.63 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | -591,000.00 |
| Jun 30, 2025 | -365,000.00 |
| Mar 31, 2025 | 361,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | -757,000.00 |
| Jun 30, 2024 | -1.88 Mn |
| Mar 31, 2024 | 689,000.00 |
| Dec 31, 2023 | -2.89 Mn |
| Sep 30, 2023 | 3.99 Mn |
| Jun 30, 2023 | -514,000.00 |
| Mar 31, 2023 | -2.95 Mn |
| Dec 31, 2022 | -1.63 Mn |
| Sep 30, 2022 | 706,000.00 |
| Jun 30, 2022 | -2.36 Mn |
| Mar 31, 2022 | -1.50 Mn |
| Dec 31, 2021 | 2.29 Mn |
| Sep 30, 2021 | -578,000.00 |